STAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more

Sanofi weighs an Insmed takeover, the FDA slams J&J over misleading bladder cancer drug claims, and more pharma news:
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive
Just in

Researchers explore possibility of a CTE blood test

Patient safety chief concerned about NHS Grampian
